课题基金 / 基金详情

Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic Minorities

Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic Minorities
解决少数种族/族裔高级心力衰竭治疗选择中的个体提供者偏见和群体决策
批准号:
9755243
负责人:
Khadijah Breathett
金额:
$17.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2023-06-30

项目摘要

项目成果

Khadijah Breathett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Bias is present in multiple facets of life and influences decision-making particularly among racial/ethnic minorities. Bias also likely plays a strong role in the process of selecting candidates for advanced heart failure therapies, including heart transplants and left ventricular assist devices, because of the subjective nature of the process. Implicit bias has been well studied in medicine but has not been found to be universally instrumental in changing outcomes, and healthcare group decision-making has not been well studied. Therefore, the application of mixed-methods to study individual healthcare provider bias and group decision-making is innovative. For the first time, the think aloud protocol, a method of elucidating decision-making thoughts for thematic qualitative analysis, and a visual analog scale survey will be used to assess individual provider bias, and the de Groot Critically Reflective Diagnosis protocol, a methodical quantification of reflective group decision-making, will be used to assess the group decision-making process for selection of candidates for advanced therapy for heart failure. We will identify the single most important subjective factor that contributes to racial/ethnic bias and lower reflective scores. An objective measurement of this factor will be used in a standardized protocol for evaluating patients for advanced therapies. Naturalistic evaluation of implementation of this protocol will lead to protocol tailoring that will provide groundwork for a pragmatic R01 trial. The findings of this study will also have implications for other populations that use multidisciplinary healthcare providers for decision-making such as selection of patients for transcatheter aortic valve replacement and transplantation of other organs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
  • 批准号:
    10474768
  • 项目类别:
  • 资助金额:
    $3.06万
  • 财政年份:
    2021
  • 负责人:
    Khadijah Breathett
  • 依托单位:
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: